Literature DB >> 26360589

Control of macrophage metabolism and activation by mTOR and Akt signaling.

Anthony J Covarrubias1, H Ibrahim Aksoylar1, Tiffany Horng2.   

Abstract

Macrophages are pleiotropic cells that assume a variety of functions depending on their tissue of residence and tissue state. They maintain homeostasis as well as coordinate responses to stresses such as infection and metabolic challenge. The ability of macrophages to acquire diverse, context-dependent activities requires their activation (or polarization) to distinct functional states. While macrophage activation is well understood at the level of signal transduction and transcriptional regulation, the metabolic underpinnings are poorly understood. Importantly, emerging studies indicate that metabolic shifts play a pivotal role in control of macrophage activation and acquisition of context-dependent effector activities. The signals that drive macrophage activation impinge on metabolic pathways, allowing for coordinate control of macrophage activation and metabolism. Here we discuss how mTOR and Akt, major metabolic regulators and targets of such activation signals, control macrophage metabolism and activation. Dysregulated macrophage activities contribute to many diseases, including infectious, inflammatory, and metabolic diseases and cancer, thus a better understanding of metabolic control of macrophage activation could pave the way to the development of new therapeutic strategies.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Akt; Immunometabolism; Macrophage activation; Macrophage metabolism; mTOR

Mesh:

Substances:

Year:  2015        PMID: 26360589      PMCID: PMC4682888          DOI: 10.1016/j.smim.2015.08.001

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  66 in total

1.  Disruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis.

Authors:  Ding Ai; Hongfeng Jiang; Marit Westerterp; Andrew J Murphy; Mi Wang; Anjali Ganda; Sandra Abramowicz; Carrie Welch; Felicidad Almazan; Yi Zhu; Yury I Miller; Alan R Tall
Journal:  Circ Res       Date:  2014-03-31       Impact factor: 17.367

2.  The macrophage paradox.

Authors:  Jordan V Price; Russell E Vance
Journal:  Immunity       Date:  2014-11-01       Impact factor: 31.745

Review 3.  Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease.

Authors:  Steven J Van Dyken; Richard M Locksley
Journal:  Annu Rev Immunol       Date:  2013-01-03       Impact factor: 28.527

4.  Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.

Authors:  Valerie A Gerriets; Rigel J Kishton; Amanda G Nichols; Andrew N Macintyre; Makoto Inoue; Olga Ilkayeva; Peter S Winter; Xiaojing Liu; Bhavana Priyadharshini; Marta E Slawinska; Lea Haeberli; Catherine Huck; Laurence A Turka; Kris C Wood; Laura P Hale; Paul A Smith; Martin A Schneider; Nancie J MacIver; Jason W Locasale; Christopher B Newgard; Mari L Shinohara; Jeffrey C Rathmell
Journal:  J Clin Invest       Date:  2014-12-01       Impact factor: 14.808

Review 5.  Dendritic cell metabolism.

Authors:  Edward J Pearce; Bart Everts
Journal:  Nat Rev Immunol       Date:  2015-01       Impact factor: 53.106

6.  Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation.

Authors:  Juan-Carlos Rodríguez-Prados; Paqui G Través; Jimena Cuenca; Daniel Rico; Julián Aragonés; Paloma Martín-Sanz; Marta Cascante; Lisardo Boscá
Journal:  J Immunol       Date:  2010-05-24       Impact factor: 5.422

7.  TSC1 controls macrophage polarization to prevent inflammatory disease.

Authors:  Linnan Zhu; Tao Yang; Longjie Li; Lina Sun; Yuzhu Hou; Xuelian Hu; Lianjun Zhang; Hongling Tian; Qingjie Zhao; Jianxia Peng; Hongbing Zhang; Ruoyu Wang; Zhongzhou Yang; Lianfeng Zhang; Yong Zhao
Journal:  Nat Commun       Date:  2014-09-01       Impact factor: 14.919

8.  The TSC-mTOR signaling pathway regulates the innate inflammatory response.

Authors:  Thomas Weichhart; Giuseppina Costantino; Marko Poglitsch; Margit Rosner; Maximilian Zeyda; Karl M Stuhlmeier; Thomas Kolbe; Thomas M Stulnig; Walter H Hörl; Markus Hengstschläger; Mathias Müller; Marcus D Säemann
Journal:  Immunity       Date:  2008-10-09       Impact factor: 31.745

9.  De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.

Authors:  Luciana Berod; Christin Friedrich; Amrita Nandan; Jenny Freitag; Stefanie Hagemann; Kirsten Harmrolfs; Aline Sandouk; Christina Hesse; Carla N Castro; Heike Bähre; Sarah K Tschirner; Nataliya Gorinski; Melanie Gohmert; Christian T Mayer; Jochen Huehn; Evgeni Ponimaskin; Wolf-Rainer Abraham; Rolf Müller; Matthias Lochner; Tim Sparwasser
Journal:  Nat Med       Date:  2014-10-05       Impact factor: 53.440

Review 10.  Metabolic reprograming in macrophage polarization.

Authors:  Silvia Galván-Peña; Luke A J O'Neill
Journal:  Front Immunol       Date:  2014-09-02       Impact factor: 7.561

View more
  111 in total

Review 1.  An evolutionary perspective on immunometabolism.

Authors:  Andrew Wang; Harding H Luan; Ruslan Medzhitov
Journal:  Science       Date:  2019-01-11       Impact factor: 47.728

Review 2.  CRISPR, Prime Editing, Optogenetics, and DREADDs: New Therapeutic Approaches Provided by Emerging Technologies in the Treatment of Spinal Cord Injury.

Authors:  Vera Paschon; Felipe Fernandes Correia; Beatriz Cintra Morena; Victor Allisson da Silva; Gustavo Bispo Dos Santos; Maria Cristina Carlan da Silva; Alexandre Fogaça Cristante; Stephanie Michelle Willerth; Florence Evelyne Perrin; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2020-01-11       Impact factor: 5.590

3.  The TORC1-activated Proteins, p70S6K and GRB10, Regulate IL-4 Signaling and M2 Macrophage Polarization by Modulating Phosphorylation of Insulin Receptor Substrate-2.

Authors:  Kristi J Warren; Xi Fang; Nagaraj M Gowda; Joshua J Thompson; Nicola M Heller
Journal:  J Biol Chem       Date:  2016-10-14       Impact factor: 5.157

4.  Altered mTORC1 signalling may contribute to macrophage dysregulation in hidradenitis suppurativa.

Authors:  Valerio De Vita
Journal:  Inflamm Res       Date:  2017-11-11       Impact factor: 4.575

Review 5.  Review: Synovial Cell Metabolism and Chronic Inflammation in Rheumatoid Arthritis.

Authors:  Jane Falconer; Anne N Murphy; Stephen P Young; Andrew R Clark; Stefano Tiziani; Monica Guma; Christopher D Buckley
Journal:  Arthritis Rheumatol       Date:  2018-06-04       Impact factor: 10.995

6.  Fgr kinase is required for proinflammatory macrophage activation during diet-induced obesity.

Authors:  Rebeca Acín-Pérez; Salvador Iborra; Yolanda Martí-Mateos; Emma C L Cook; Ruth Conde-Garrosa; Anton Petcherski; Mª Del Mar Muñoz; Raquel Martínez de Mena; Karthickeyan Chella Krishnan; Concepción Jiménez; Juan Pedro Bolaños; Markku Laakso; Aldon J Lusis; Orian S Shirihai; David Sancho; José Antonio Enríquez
Journal:  Nat Metab       Date:  2020-09-17

Review 7.  MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells.

Authors:  Russell G Jones; Edward J Pearce
Journal:  Immunity       Date:  2017-05-16       Impact factor: 31.745

Review 8.  AKT/PKB Signaling: Navigating the Network.

Authors:  Brendan D Manning; Alex Toker
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

9.  Macrophages Promote Oxidative Metabolism To Drive Nitric Oxide Generation in Response to Trypanosoma cruzi.

Authors:  Sue-Jie Koo; Imran H Chowdhury; Bartosz Szczesny; Xianxiu Wan; Nisha J Garg
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

10.  Post-sepsis immunosuppression depends on NKT cell regulation of mTOR/IFN-γ in NK cells.

Authors:  Edy Y Kim; Hadas Ner-Gaon; Jack Varon; Aidan M Cullen; Jingyu Guo; Jiyoung Choi; Diana Barragan-Bradford; Angelica Higuera; Mayra Pinilla-Vera; Samuel Ap Short; Antonio Arciniegas-Rubio; Tomoyoshi Tamura; David E Leaf; Rebecca M Baron; Tal Shay; Michael B Brenner
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.